We are live on ! Find out more
ARMP icon

Armata Pharmaceuticals
ARMP

21 hedge funds and large institutions have $488K invested in Armata Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

24% more funds holding

Funds holding: 17 → 21 (+4)

2% more capital invested

Capital invested by funds: $479K → $488K (+$9K)

Holders
21
Holders Change
+4
Holders Change %
+23.53%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$72.7K
2
Renaissance Technologies
Renaissance Technologies
New York
+$27.2K
3
Citadel Advisors
Citadel Advisors
Florida
+$18.6K
4
PAM
Panagora Asset Management
Massachusetts
+$15.4K
5
SXL
Summit X LLC
Missouri
+$6.32K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$136K
2
TSS
Two Sigma Securities
New York
-$18K
3
VF
Virtu Financial
New York
-$16.6K
4
UBS Group
UBS Group
Switzerland
-$16K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$140K +$27.2K +1,843 +23%
Vanguard Group
2
Vanguard Group
Pennsylvania
$99K +$72.7K +4,925 +235%
ARTA
3
A.R.T. Advisors
New York
$65K +$6.26K +424 +10%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$37K – – –
VF
5
Virtu Financial
New York
$28K -$16.6K -1,123 -36%
SXL
6
Summit X LLC
Missouri
$19K +$6.32K +428 +46%
PAM
7
Panagora Asset Management
Massachusetts
$19K +$15.4K +1,040 +366%
Citadel Advisors
8
Citadel Advisors
Florida
$18K +$18.6K +1,260 New
MP
9
MSD Partners
New York
$15K – – –
SF
10
Synovus Financial
Georgia
$15K – – –
Northwestern Mutual Wealth Management
11
Northwestern Mutual Wealth Management
Wisconsin
$12K +$4.22K +286 +50%
H
12
HoyleCohen
California
$11K +$11.6K +786 New
Acadian Asset Management
13
Acadian Asset Management
Massachusetts
$5K +$5.43K +368 New
UBS Group
14
UBS Group
Switzerland
$3K -$16K -1,081 -82%
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$1K – – –
LTFS
16
Ladenburg Thalmann Financial Services
Florida
$1K +$532 +36 +600%
SM
17
Sabby Management
Florida
– -$136K -10,661 Closed
TSS
18
Two Sigma Securities
New York
– -$18K -1,430 Closed
SWP
19
Stratos Wealth Partners
Ohio
– +$15 +1 New
TJHA
20
Thomas J. Herzfeld Advisors
Florida
– +$103 +7 New
Bank of America
21
Bank of America
North Carolina
– +$118 +8 New

ARMP Hedge Fund Activity: Q4 2017 in Review

21 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q4 2017, worth a combined $488K — up 1.9% from $479K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ARMP positions and 2 closed out — a net gain of 4 holders — while 7 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, adding an estimated $72.7K. The largest seller was Sabby Management, exiting entirely with an estimated $136K sold.

  • 21 institutional investors held Armata Pharmaceuticals (ARMP) as of Q4 2017, up from 17 in Q3 2017.
  • Funds reported $488K of Armata Pharmaceuticals stock for Q4 2017, up 1.9% quarter-over-quarter.
  • 6 funds opened new Armata Pharmaceuticals positions in Q4 2017 and 2 closed out, a net change of +4 holders.
  • The largest Armata Pharmaceuticals buyer in Q4 2017 was Vanguard Group, an estimated $72.7K added.
  • The largest Armata Pharmaceuticals seller in Q4 2017 was Sabby Management, an estimated $136K sold.

Based on aggregated 13F filings for Q4 2017.